Alliancebernstein L.P. Purchases 126,147 Shares of Mettler-Toledo International, Inc. $MTD

Key Points

• Alliancebernstein L.P. increased its stake in Mettler-Toledo International by 21.6%, now owning approximately 3.41% of the company, valued at around $837.7 million.
• Institutional investors hold 95.07% of Mettler-Toledo International's stock, indicating a strong institutional interest in the company.
• The company's latest earnings report showed a 3.9% year-over-year revenue increase, with earnings per share beating analyst estimates by $0.51.

Alliancebernstein L.P. grew its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 21.6% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 709,328 shares of the medical instruments supplier's stock after purchasing an additional 126,147 shares during the period. Alliancebernstein L.P. owned about 3.41% of Mettler-Toledo International worth $837,653,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Greenleaf Trust boosted its position in shares of Mettler-Toledo International by 1.2% during the 1st quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock worth $1,030,000 after acquiring an additional 10 shares in the last quarter. Brooklyn Investment Group boosted its position in shares of Mettler-Toledo International by 12.8% during the 1st quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier's stock worth $104,000 after acquiring an additional 10 shares in the last quarter. Albion Financial Group UT boosted its position in shares of Mettler-Toledo International by 1.5% during the 1st quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock worth $890,000 after acquiring an additional 11 shares in the last quarter. Sequoia Financial Advisors LLC boosted its position in shares of Mettler-Toledo International by 1.8% during the 1st quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after acquiring an additional 11 shares in the last quarter. Finally, TD Private Client Wealth LLC boosted its position in shares of Mettler-Toledo International by 5.4% during the 1st quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier's stock worth $253,000 after acquiring an additional 11 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently issued reports on MTD. Robert W. Baird increased their price target on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. Barclays began coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price target on the stock. Bank of America increased their price target on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research report on Thursday, June 26th. Evercore ISI dropped their price objective on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a research note on Monday, August 4th. Finally, UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and dropped their price objective for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $1,311.11.

Insider Buying and Selling

In other Mettler-Toledo International news, insider Gerry Keller sold 165 shares of the company's stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the sale, the insider directly owned 94 shares of the company's stock, valued at approximately $123,012.16. This represents a 63.71% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Shawn Vadala sold 300 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total value of $397,500.00. Following the completion of the transaction, the chief financial officer owned 5,095 shares in the company, valued at $6,750,875. The trade was a 5.56% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,827 shares of company stock worth $2,371,208 in the last quarter. Insiders own 1.94% of the company's stock.

Mettler-Toledo International Stock Up 1.3%

Shares of MTD stock traded up $16.86 during trading hours on Friday, hitting $1,304.65. 95,040 shares of the company's stock traded hands, compared to its average volume of 128,164. The stock's 50 day simple moving average is $1,251.17 and its 200 day simple moving average is $1,186.06. The stock has a market cap of $26.88 billion, a PE ratio of 33.04, a price-to-earnings-growth ratio of 3.92 and a beta of 1.37. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The firm had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. During the same quarter last year, the firm earned $9.65 earnings per share. The company's revenue for the quarter was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, equities research analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.